{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:40:32Z","timestamp":1785598832384,"version":"3.56.0"},"reference-count":41,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.1536\/ihj.25-557","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:10:49Z","timestamp":1785449449000},"page":"314-324","source":"Crossref","is-referenced-by-count":1,"title":["Association between Circulating Interleukin-2 and Clinical Outcomes in Patients with Acute Decompensated Heart Failure"],"prefix":"10.1536","volume":"67","author":[{"given":"Chenyu","family":"Wang","sequence":"first","affiliation":[{"name":"School of Medicine, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoliang","family":"Yan","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"},{"name":"Department of Cardiology, Zhongda Hospital, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"},{"name":"Department of Cardiology, Zhongda Hospital, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixin","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"},{"name":"Department of Cardiology, Zhongda Hospital, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qiao","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"},{"name":"Department of Cardiology, Zhongda Hospital, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchun","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Medicine, Southeast University"},{"name":"Department of Cardiology, Zhongda Hospital, Southeast University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Njoroge JN, Teerlink JR. Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure. Circ Res 2021; 128: 1468-86.","DOI":"10.1161\/CIRCRESAHA.121.318186"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 2023; 118: 3272-87.","DOI":"10.1093\/cvr\/cvac013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wang H, Li Y, Chai K, <i>et al<\/i>. Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study. Lancet Glob Health 2024; 12: e611-22.","DOI":"10.1016\/S2214-109X(23)00605-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pranata R, Tondas AE, Yonas E, <i>et al<\/i>. Differences in clinical characteristics and outcome of de novo heart failure compared to acutely decompensated chronic heart failure - systematic review and meta-analysis. Acta Cardiol 2021; 76: 410-20.","DOI":"10.1080\/00015385.2020.1747178"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lassus JPE, Siiril\u00e4-Waris K, Nieminen MS, <i>et al<\/i>. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure. Int J Cardiol 2013; 168: 458-62.","DOI":"10.1016\/j.ijcard.2012.09.128"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in Heart Failure. J Am Coll Cardiol 2020; 75: 1324-40.","DOI":"10.1016\/j.jacc.2020.01.014"},{"key":"7","first-page":"e1054","volume":"135","year":"2017","unstructured":"7. Chow SL, Maisel AS, Anand I, <i>et al<\/i>. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2017; 135: e1054-91.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Huang R, Wang Z, Chen J, <i>et al<\/i>. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol 2022; 21: 88.","DOI":"10.1186\/s12933-022-01507-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miettinen KH, Lassus J, Harjola VP, <i>et al<\/i>. Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 2008; 10: 396-403.","DOI":"10.1016\/j.ejheart.2008.02.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, <i>et al<\/i>. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. J Am Coll Cardiol 2019; 73: 1016-25.","DOI":"10.1016\/j.jacc.2018.11.054"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA. IL-2, -7, and -15, but Not Thymic Stromal Lymphopoeitin, Redundantly Govern CD4+Foxp3+ Regulatory T Cell Development. J Immunol 2008; 181: 3285-90.","DOI":"10.4049\/jimmunol.181.5.3285"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bartekova M, Radosinska J, Jelemensky M, Dhalla NS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail Rev 2018; 23: 733-58.","DOI":"10.1007\/s10741-018-9716-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liao W, Lin J-X, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 2011; 23: 598-604.","DOI":"10.1016\/j.coi.2011.08.003"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Sriranjan R, Zhao TX, Tarkin J, <i>et al<\/i>. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. BMJ Open 2022; 12: e062602.","DOI":"10.1136\/bmjopen-2022-062602"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Thavendiranathan P, Verhaert D, Kendra KL, Raman SV. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma. Br J Radiol 2011; 84: e99-e102.","DOI":"10.1259\/bjr\/13448473"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lagan J, Naish JH, Fortune C, <i>et al<\/i>. Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study. Diagnostics (Basel) 2022; 12: 1352.","DOI":"10.3390\/diagnostics12061352"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Talukdar D, Haldar AK, Kumar S, <i>et al<\/i>. Leukocyte infiltration and cross-talk with cardiomyocytes exploit intracellular stress pathways in dilated cardiomyopathy of idiopathic origin. Mol Biol Rep 2024; 51: 1090.","DOI":"10.1007\/s11033-024-10028-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Carris NW, Mhaskar R, Coughlin E, Bracey E, Tipparaju SM, Halade GV. Novel biomarkers of inflammation in heart failure with preserved ejection fraction: analysis from a large prospective cohort study. BMC Cardiovasc Disord 2022; 22: 221.","DOI":"10.1186\/s12872-022-02656-z"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Parissis JT, Farmakis D, Nikolaou M, <i>et al<\/i>. Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study. Eur J Heart Fail 2009; 11: 967-72.","DOI":"10.1093\/eurjhf\/hfp125"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Santoro F, Tarantino N, Ferraretti A, <i>et al<\/i>. Serum interleukin 6 and 10 levels in Takotsubo cardiomyopathy: Increased admission levels may predict adverse events at follow-up. Atherosclerosis 2016; 254: 28-34.","DOI":"10.1016\/j.atherosclerosis.2016.09.012"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Levick SP, Goldspink PH. Could interferon-gamma be a therapeutic target for treating heart failure? Heart Fail Rev 2014; 19: 227-36.","DOI":"10.1007\/s10741-013-9393-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. McDonagh TA, Metra M, Adamo M, <i>et al<\/i>. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42: 3599-726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pocock SJ, Ariti CA, McMurray JJV, <i>et al<\/i>. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404-13.","DOI":"10.1093\/eurheartj\/ehs337"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Santas E, Villar S, Palau P, <i>et al<\/i>. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure. Sci Rep 2024; 14: 21672.","DOI":"10.1038\/s41598-024-72137-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 2020; 17: 269-85.","DOI":"10.1038\/s41569-019-0315-x"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996; 94: 2930-7.","DOI":"10.1161\/01.CIR.94.11.2930"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhang H, Dhalla NS. The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. Int J Mol Sci 2024; 25: 1082.","DOI":"10.3390\/ijms25021082"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev 2010; 15: 331-41.","DOI":"10.1007\/s10741-009-9140-3"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Limas CJ, Goldenberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 1995; 91: 631-4.","DOI":"10.1161\/01.CIR.91.3.631"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-7.","DOI":"10.1536\/ihj.52.382"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shouse AN, LaPorte KM, Malek TR. Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer. Immunity 2024; 57: 414-28.","DOI":"10.1016\/j.immuni.2024.02.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wang H, Hou L, Kwak D, <i>et al<\/i>. Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression. Hypertension 2016; 68: 114-22.","DOI":"10.1161\/HYPERTENSIONAHA.116.07084"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Koch M, Savvatis K, Scheeler M, <i>et al<\/i>. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy. Int Immunopharmacol 2010; 10: 207-12.","DOI":"10.1016\/j.intimp.2009.11.001"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Laroumanie F, Douin-Echinard V, Pozzo J, <i>et al<\/i>. CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 2014; 129: 2111-24.","DOI":"10.1161\/CIRCULATIONAHA.113.007101"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nevers T, Salvador AM, Grodecki-Pena A, <i>et al<\/i>. Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure. Circ Heart Fail 2015; 8: 776-87.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Garofalo M, Corso R, Tomasoni D, <i>et al<\/i>. Inflammation in acute heart failure. Front Cardiovasc Med 2023; 10: 1235178.","DOI":"10.3389\/fcvm.2023.1235178"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Colombo PC, Onat D, Harxhi A, <i>et al<\/i>. Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J 2014; 35: 448-54.","DOI":"10.1093\/eurheartj\/eht456"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Pugliese NR, Fabiani I, Conte L, <i>et al<\/i>. Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study. J Cardiovasc Med (Hagerstown) 2020; 21: 494-502.","DOI":"10.2459\/JCM.0000000000000974"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Alogna A, Koepp KE, Sabbah M, <i>et al<\/i>. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail 2023; 11: 1549-61.","DOI":"10.1016\/j.jchf.2023.06.031"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Hanberg JS, Rao VS, Ahmad T, <i>et al<\/i>. Inflammation and Cardio-Renal Interactions in Heart Failure: A Potential Role for Interleukin-6. Eur J Heart Fail 2018; 20: 933-4.","DOI":"10.1002\/ejhf.963"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Scicchitano P, De Feo D, Iacoviello M, <i>et al<\/i>. Congestion and systemic inflammation in acute heart failure: correlations and prognostic role. Front Cardiovasc Med 2025; 12: 1695500.","DOI":"10.3389\/fcvm.2025.1695500"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/4\/67_25-557\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:14:05Z","timestamp":1785557645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/4\/67_25-557\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-557","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"25-557"}}